Johnson & Johnson
$170.219876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$170.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.33 (+1.39%) As of 5:49 PM UTC today
Why Robinhood?
You can buy or sell JNJ and other stocks, options, and ETFs commission-free!
About JNJ
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. The listed name for JNJ is Johnson & Johnson.
CEO
Alex Gorsky
Employees
132,200
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
436.80B
Price-Earnings Ratio
30.94
Dividend Yield
2.33
Average Volume
10.04M
High Today
$170.53
Low Today
$167.91
Open Price
$168.08
Volume
4.73M
52 Week High
$173.65
52 Week Low
$109.16
Collections
JNJ News
Reuters7h
Racing the virus: Why tweaking the vaccines won't be simple
FILE PHOTO: Paul Stoffels, Chief Scientific Officer of Johnson & Johnson attends the annual meeting of the World Economic Forum (WEF) in Davos, Switzerland Janu
Analyst Ratings
67%
of 18 ratings
Buy
67%
Hold
33%
Sell
0%
JNJ Earnings
$1.48
$1.85
$2.21
$2.58
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$1.82 per share
Actual
$1.86 per share
You May Also Like
More JNJ News
Yahoo FinanceJan 26
Johnson & Johnson CFO on COVID-19 vaccine: ‘We are very much on track to meet the capacity requirements’
Johnson & Johnson reported fourth quarter earnings that beat expectations. Johnson & Johnson CFO Joe Wolk joins Yahoo Finance Live to discuss.
Video Transcript
MarketWatchJan 26
Dow's 31-point climb highlighted by gains in Johnson & Johnson, 3M shares
The Dow Jones Industrial Average is trading up Tuesday morning with shares of Johnson & Johnson and 3M leading the way for the price-weighted average. Shares of
ReutersJan 26
Johnson & Johnson expects COVID-19 vaccine data next week
(Reuters) - Johnson & Johnson on Tuesday said it expected to report eagerly-awaited data on its COVID-19 vaccine early next week, and that it would be able to m
New York TimesJan 26
The White House extends Covid-19-related travel bans on Brazil and much of Europe and adds South Africa.
The new director of the Centers for Disease Control and Prevention, Dr. Rochelle Walensky, has predicted the vaccine supply would not increase until late March.
ReutersJan 26
S&P 500, Dow to open higher on upbeat corporate earnings; Fed meeting in focus
(Reuters) - The S&P 500 and the Dow were set to open slightly higher on Tuesday, helped by positive earnings updates from a slew of companies including General
